Navigation

cetirizine (Zyrtec, Zyrtec Allergy, Children's Zyrtec Allergy, Children's Zyrtec Hives Relief, PediaCare Children's 24 Hour Allergy, Aller-Tec, Wal-Zyr)

 

Classes: Antihistamines, 2nd Generation

Dosing and uses of Zyrtec (cetirizine)

 

Adult dosage forms and strengths

tablet

  • 5mg
  • 10mg

tablet, oral-disintegrating

  • 10mg

tablet, chewable

  • 5mg
  • 10mg

syrup

  • 5mg/5mL

solution

  • 5mg/5mL

 

Allergies/Hay Fever/Urticaria

Perennial and seasonal allergic and vasomotor rhinitis; relief of symptoms from colds, urticaria, angioedema, anaphylactic reactions, pruritus, allergic conjunctivitis

5-10 mg PO qDay, depending on severity of symptoms; not to exceed 10 mg qDay

 

Dosing Modifications

Renal impairment

  • GFR >50 mL/min: Dose adjustment not necessary
  • GFR ≤ 50 mL/min: 5 mg PO qDay
  • Peritoneal dialysis: 5 mg PO qDay
  • Intermittent hemodialysis: 5 mg PO qDay; may also administer 3 times weekly

Hepatic impairment

  • Dose adjustment not provided by manufacturer's label

 

Administration

May be taken with or without food

 

Pediatric dosage forms and strengths

tablet

  • 5mg
  • 10mg

tablet, oral-disintegrating

  • 10mg

tablet, chewable

  • 5mg
  • 10mg

syrup

  • 5mg/5mL

solution

  • 5mg/5mL

 

Allergies/Hay Fever/Urticaria

Perennial and seasonal allergic and vasomotor rhinitis

<2 years: Safety and efficacy not established

2-6 years: 2.5 mg (0.5 teaspoon) oral solution PO qDay; can increase to 5 mg PO qDay or 2.5 mg PO twice daily; not to exceed 5 mg qDay

>6 years: 5-10 mg PO qDay, depending on severity of symptoms; not to exceed 10 mg qDay

 

Dosing Modifications

Renal impairment

  • GFR ≥30 mL/min/1.73 m²: Dose adjustment not necessary
  • GFR 10-29 mL/min/1.73 m²: Decrease dose by 50%
  • GFR < 10 mL/min/1.73 m²: Not recommended
  • Intermittent hemodialysis or peritoneal dialysis: Decrease dose by 50%

Hepatic impairment

  • Dose adjustment not provided by manufacturer's label

 

Administration

May be taken with or without food

 

Geriatric dosage forms and strengths

5 mg PO qDay; may increase to 10 mg/day mazimum, depending on severity of symptoms; not to exceed 5 mg qDay in patients >77 years

 

Zyrtec (cetirizine) adverse (side) effects

>10%

Somnolence (2-14%)

Headache (11-14%)

 

1-10%

Fatigue (5.9%)

Dry mouth (5%)

Dizziness (2%)

Diarrhea (2-3%)

Malaise (4%)

Bronchospasm (2-3%)

Vomiting (2-3%)

Epistaxis (2-4%)

 

<1%

Stomach pain

Drowsiness

Angioedema

Fussiness

Hallucinations

Hypotension

Tremor

Tongue discoloration

 

Warnings

Contraindications

Documented hypersensitivity to cetirizine, hydroxyzine

 

Cautions

Avoid alcohol, sedatives, and tranquilizers, due to increased risk of drowsiness

May cause CNS depression; avoid activities requiring mental alertness until accustomed to medication

Use caution in hepatic and renal impairment

The elderly may be more sensitive to adverse effects

 

Pregnancy and lactation

Pregnancy category: B; C for Zyrtec-D 12 Hour

Lactation: Excreted in breast milk; use not recommended

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Zyrtec (cetirizine)

Mechanism of action

Histamine H1-receptor antagonist; competes with histamine on effector cells in the gastrointestinal tract, blood vessels and respiratory tract

 

Absorption

Peak plasma concentration: 114 ng/mL

Peak serum time: 1 hr

Duration: >24 hr ( suppression of skin wheal and flare reactions

 

Distribution

Protein bound: 93%

Vd: 0.56 L/kg

 

Metabolism

Metabolism: Liver; low first pass

Limited extent by oxidative O-dealkylation to inactive metabolite

 

Elimination

Half-life: 7.9hr

Excretion: Urine (70%); feces (10%)